Stockreport

Kiniksa Announces Positive Final Data from Phase 1 Trial of KPL-404

Kiniksa Pharmaceuticals, Ltd. - Class A  (KNSA) 
Last kiniksa pharmaceuticals, ltd. - class a earnings: 8/12 04:02 pm Check Earnings Report
PDF - Highest dose cohorts confirm and extend previously-reported 3 mg/kg IV cohort data -- 10 mg/kg IV dose provides full receptor occupancy through Day 71 and complete sup [Read more]